What this market covers
Diagnosis and treatment of reduced sperm production or function, including medicines, surgery and assisted reproduction. Buyers are fertility clinics, urologists and couples seeking care.
Typical segments
- Semen analysis
- Hormone therapy
- Varicocele surgery
- Sperm retrieval and IVF
- Supplements
Why this market is moving now
- Clinical research is active, with studies recruiting now.
Key figures
Each figure names the source it came from. Open the source list below to read the quoted line.
| Figure | Value | Year | Source |
|---|---|---|---|
| The EU had 3,116 enterprises in NACE class C2120 (Manufacture of pharmaceutical preparations) in 2023. | 3,116 enterprises | 2023 | Eurostat |
| EU enterprises in NACE class C2120 had net turnover of €428.65 billion in 2023. | 428.65 EUR billion | 2023 | Eurostat |
| NACE class C2120 employed 600,730 people across the EU in 2023. | 600,730 persons employed | 2023 | Eurostat |
| ClinicalTrials.gov lists 480 registered studies for the condition "Male Infertility". | 480 registered studies | 2026 | U.S. National Library of Medicine |
| 56 of those studies were recruiting participants when checked in November 2026. | 56 recruiting studies | 2026 | U.S. National Library of Medicine |
| PubMed indexed 1,449 papers mentioning "male infertility" in the title or abstract in 2025. | 1,449 papers | 2025 | U.S. National Library of Medicine |
Sources and method
The figures on this page come from the public sources listed below. Read how we work.
- Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
Quoted lines
- Figure 1
sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs ENT_NR, 2023, 3116
- Figure 2
sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs NETTUR_MEUR, 2023, 428651
- Figure 3
sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs EMP_NR, 2023, 600730
- Figure 1
- U.S. National Library of Medicine: ClinicalTrials.gov API v2, condition "Male Infertility" (2026-11-04)
Quoted lines
- Figure 4
query.cond=Male Infertility totalCount 480
- Figure 4
- U.S. National Library of Medicine: ClinicalTrials.gov API v2, condition "Male Infertility", status recruiting (2026-11-04)
Quoted lines
- Figure 5
filter.overallStatus=RECRUITING totalCount 56
- Figure 5
- U.S. National Library of Medicine: PubMed search "male infertility"[tiab] AND 2025[dp] (2026-11-04)
Quoted lines
- Figure 6
esearch count 1449
- Figure 6
Buyers and suppliers
Who buys
- Fertility clinics
- Urologists
- Couples seeking care
What the full report covers
- 01Executive summary
The answer in one page: size, direction and what moves it - 02Market definition and scope
What is in and out of the United States market - 03Market size, 2021 to 2025
Historical series and growth rates - 04Outlook to 2031
Base, low and high scenarios with stated assumptions - 05Rules, policy and deadlines
Regulation and programmes that change demand - 06Drivers and barriers
What accelerates or slows adoption, by customer segment - 07Prices, costs and margins
Unit economics where public data allows - 08Competitive landscape
8 to 12 company profiles with recent moves - 09Opportunities and risks
For new entrants, suppliers and investors - 10Method and sources
Every assumption and source, listed
Included with the full report
- PDF report, 40 to 60 pages
- Excel data pack
- Ready-to-use charts
- Method note and assumptions
- Written to order in 5 working days
Frequently asked questions
How many clinical trials study Male Infertility?
ClinicalTrials.gov lists 480 registered studies.
How many EU companies are in the male infertility industry?
Eurostat counts 3,116 enterprises in NACE class C2120 (Manufacture of pharmaceutical preparations).
Free sample
Get a free sample of this report
We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.
- Full table of contents
- Two sample chapters
- Method note and data outline